Drug Manufacturers Under Consideration – WCRX, TEVA, AGN, DVAX
Houston, TX – February 6, 2013 — (Net PR News) – AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Today’s Stocks in focus are: NASDAQ:WCRX, NYSE:TEVA, NYSE:AGN, NASDAQ:DVAX
Warner Chilcott Plc (NASDAQ:WCRX) unveiled that, on Friday, February 8, 2013, before opening the regular trading hours of the stock exchange, it will release its 2013 financial guidance. To review the company’s guidance, on Friday, February 8 at 8:00 a.m. (Eastern Time), it will present a conference call for all concerned parties.
Warner Chilcott Plc closed at the price of $14.08 after opening at $14.42. Stock traded during its last trading session with the total volume of 13.68 million shares, as compared to its average volume of 4.71million shares.
Is WCRX A Solid Investment At These Levels? Find Out Exactly Where WCRX Is Headed With This TREND ANALYSIS REPORT
During the previous session, the company’s minimum price was $14.04, while it touched its highest price for the day at $14.87. WCRX’s beta value stands at 1.17 points. During its last one month, the company gained 9.49%, while its last 5 days shows an upsurge of 4.37%.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) reported the gain of 0.08% and closed at $37.74 with the total traded volume of 5.81 million shares. The stock’s opening price was $37.83. The company has a total of 868.00million outstanding shares and its total market capitalization is $32.76 billion.
Get A Free Report And Detailed Analysis On TEVA CLICK HERE To Read
The 52-week price range of the stock remained $36.63 – $46.38, while during last trade its minimum price was $37.74 and it gained its highest price of $38.01. The Company’s last 5 days shows an uptrend of 0.03%.
Allergan, Inc. (NYSE:AGN) reported its operating results for the fiscal quarter ended December 31, 2012. The company’s Board of Directors has announced its fourth quarter dividend, which is payable on March 21, 2013, priced at $0.05 per share to stockholders of record on February 28, 2013.
How Should Investors React To AGN Now? Find Out In This TREND ANALYSIS REPORT
Allergan, Inc. stock’s trade opened at $105.17 and, as day trade closed, its price was $106.70 after scoring +1.55%. The market capitalization of AGN was $32.06 billion. Total traded volume of the stock was 1.82 million shares, while the company’s average volume remained 1.73 million shares. AGN’s day range was $104.96 – $107.59, while its 52 week range was $81.28 – $107.69. The 5 days performance graph showed it as a percentage decliner of -0.48%.
Dynavax Technologies Corporation (NASDAQ:DVAX) reported the increase of 2.33% to close at $3.08 with the overall traded volume of 3.36 million shares. Its market capitalization was $550.42 million. Its beta value stands at 2.95 times and earning per share was $-0.33.
Dynavax Technologies Corporation (NASDAQ:DVAX) has the total of 178.71 million outstanding shares. During last trade, the company’s minimum price was $3.01, while it touched its highest price of $3.12. The Company’s year to date performance remained optimistic with the gain of 8.07%. If we look at its last 6 months of trade, that is in the bearish zone with the loss of -18.95%.
How Should Investors Trade DVAX Now? Don’t Trade DVAX Until You Read This TREND ANALYSIS REPORT
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.